These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19056598)

  • 1. Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states.
    Perez-Martinez P; Corella D; Shen J; Arnett DK; Yiannakouris N; Tai ES; Orho-Melander M; Tucker KL; Tsai M; Straka RJ; Province M; Kai CS; Perez-Jimenez F; Lai CQ; Lopez-Miranda J; Guillen M; Parnell LD; Borecki I; Kathiresan S; Ordovas JM
    Am J Clin Nutr; 2009 Jan; 89(1):391-9. PubMed ID: 19056598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
    Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The -1131T>C SNP of the APOA5 gene modulates response to fenofibrate treatment in patients with the metabolic syndrome: a postprandial study.
    Cardona F; Guardiola M; Queipo-Ortuño MI; Murri M; Ribalta J; Tinahones FJ
    Atherosclerosis; 2009 Sep; 206(1):148-52. PubMed ID: 19344899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The -1131T-->C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men.
    Jang Y; Kim JY; Kim OY; Lee JE; Cho H; Ordovas JM; Lee JH
    Am J Clin Nutr; 2004 Oct; 80(4):832-40. PubMed ID: 15447887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of low-fat meal and high-fat meal on postprandial lipemic response in non-obese men according to the -1131T>C polymorphism of the apolipoprotein A5 (APOA5) gene (randomized cross-over design).
    Kim JY; Kim OY; Koh SJ; Jang Y; Yun SS; Ordovas JM; Lee JH
    J Am Coll Nutr; 2006 Aug; 25(4):340-7. PubMed ID: 16943456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
    Liu Y; Ordovas JM; Gao G; Province M; Straka RJ; Tsai MY; Lai CQ; Zhang K; Borecki I; Hixson JE; Allison DB; Arnett DK
    Pharmacogenet Genomics; 2009 Feb; 19(2):161-9. PubMed ID: 19057464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of apolipoprotein A5 (APOA5), glucokinase (GCK) and glucokinase regulatory protein (GCKR) polymorphisms and lifestyle factors with the risk of dyslipidemia and dysglycemia in Japanese - a cross-sectional data from the J-MICC Study.
    Hishida A; Morita E; Naito M; Okada R; Wakai K; Matsuo K; Nakamura K; Takashima N; Suzuki S; Takezaki T; Mikami H; Ohnaka K; Watanabe Y; Uemura H; Kubo M; Tanaka H; Hamajima N
    Endocr J; 2012; 59(7):589-99. PubMed ID: 22517333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population.
    Sánchez-Moreno C; Ordovás JM; Smith CE; Baraza JC; Lee YC; Garaulet M
    J Nutr; 2011 Mar; 141(3):380-5. PubMed ID: 21209257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study.
    Irvin MR; Kabagambe EK; Tiwari HK; Parnell LD; Straka RJ; Tsai M; Ordovas JM; Arnett DK
    Circ Cardiovasc Genet; 2010 Oct; 3(5):462-7. PubMed ID: 20729559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of high-calorie meal consumption on oxidative stress and endothelial dysfunction in healthy male adults.
    Kackov S; Simundic AM; Nikolac N; Celap I; Dukic L; Ruzic D; Bilusic M
    Physiol Res; 2013; 62(6):643-52. PubMed ID: 23869888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia.
    De Castro-Orós I; Cenarro A; Tejedor MT; Baila-Rueda L; Mateo-Gallego R; Lamiquiz-Moneo I; Pocoví M; Civeira F
    Circ Cardiovasc Genet; 2014 Dec; 7(6):814-21. PubMed ID: 25176936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population.
    Moreno-Luna R; Perez-Jimenez F; Marin C; Perez-Martinez P; Gomez P; Jimenez-Gomez Y; Delgado-Lista J; Moreno JA; Tanaka T; Ordovas JM; Lopez-Miranda J
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2280-5. PubMed ID: 17356049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
    Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
    J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
    Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
    Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common functional variants of APOA5 and GCKR accumulate gradually in association with triglyceride increase in metabolic syndrome patients.
    Hadarits F; Kisfali P; Mohás M; Maász A; Duga B; Janicsek I; Wittmann I; Melegh B
    Mol Biol Rep; 2012 Feb; 39(2):1949-55. PubMed ID: 21643755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
    Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
    Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population.
    Matsunaga A; Arishima H; Niimura H; Zhang B; Uehara Y; Ohwaki K; Morita M; Hayashida K; Saku K
    Circ J; 2007 May; 71(5):746-52. PubMed ID: 17457003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
    Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
    Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOA5 genetic and epigenetic variability jointly regulate circulating triacylglycerol levels.
    Oliva I; Guardiola M; Vallvé JC; Ibarretxe D; Plana N; Masana L; Monk D; Ribalta J
    Clin Sci (Lond); 2016 Nov; 130(22):2053-2059. PubMed ID: 27613158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional variants of glucokinase regulatory protein and apolipoprotein A5 genes in ischemic stroke.
    Járomi L; Csöngei V; Polgár N; Szolnoki Z; Maász A; Horvatovich K; Faragó B; Sipeky C; Sáfrány E; Magyari L; Kisfali P; Mohás M; Janicsek I; Lakner L; Melegh B
    J Mol Neurosci; 2010 May; 41(1):121-8. PubMed ID: 19847674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.